Press Release: Sanofi and CD&R sign Opella share purchase agreement

Sanofi Signs Share Purchase Deal To Sell 50% Controlling Stake In Opella To CD&R

Sanofi Consumer Healthcare India Announces Major Stake Acquisition Deal

Sanofi’s Dupixent Achieves FDA Priority Review for Bullous Pemphigoid Treatment

Sanofi, CD&R Sign Opella Share Purchase Agreement -February 19, 2025 at 01:35 am EST

bluebird bio ends lease agreement with Aventis and Meta By Investing.com